image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Primary Recommendations

Dr Martens - Iconic leather shoe brand sees £6 billion international sales opportunity

August 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • DOCS
  • Price:
  • 241p
One of the effects of a prolonged downturn in share prices is that good companies get sold off with the bad and ugly, but that can lead to outstanding opportunities. One such example is iconic shoe brand Dr Martens, which was brought to the main market by private equity firm Permira (which still retains 36%) in January  2021 at 370p and after soaring to over £5 has been battered along with everything else. However, the company, famous for its distinctive leather uppers and yellow stitching, has enjoyed an outstanding growth record in recent years with revenues increasing from £291m in the year ended March 2017 to £908m in FY’22, leading to a more than five-fold surge in EBITDA from £37.5m to £263m. Last year (FY’22) alone saw sales and E ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Dr Martens - D2C to drive margins higher (February 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe

SUBSCRIBE NOW